Neoplasms, Colorectal Recruiting Phase 4 Trials for Regorafenib (DB08896)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03564938Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).Treatment